Exhibit 4.11

  

  

  

  

  

  
    
      
        

      

      
         Investor PresentationTSX: TMD | Nasdaq: TMDI  March 18, 2019 

      

    

     

    
      
        


    

    
      
        

      

      
         A final prospectus containing important information relating to the securities described in this document
            has been filed with the securities regulatory authorities in the provinces of British Columbia, Alberta and Ontario. A copy of the final prospectus, and any amendment, is required to be delivered with this document. This document does not
            provide full disclosure of all material facts relating to the securities offered. Investors should read the final prospectus and any amendment for disclosure of those facts, especially risk factors relating to the securities offered, before
            making an investment decision.The Company has filed a registration statement with the United States Securities and Exchange Commission (the “SEC”) for an offering of units. Before you invest, you should read the prospectus in that registration
            statement and other documents the issuer has filed and will file with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov.
            Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus, as supplemented, if you request it by contacting the Chief Financial Officer of the Company at 170 University
            Avenue, Suite 1000, Toronto, Ontario, M5H 3B3, Telephone: (416) 548-7522.   Disclaimer 

      

    

     

    
      
        


    

    
      
        

      

      
         This presentation contains “forward-looking information” and "forward-looking statements" which relate to
            future events or future performance and reflect the current expectations and assumptions of management of the Company's future growth, results of operations, performance and business prospects, opportunities, and illustrations and prototypes of
            the SPORT Surgical Systems. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate”, “project”, “predict”, “target”, ”potential”, and similar expressions have been used
            to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant
            risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance, achievements or technological development and implementation to be materially different from any future results, performance, achievements
            or technological development and implementation that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors" section of the Company's Annual Information Form in respect
            of the fiscal year ended December 31, 2017 and other information contained in the Company’s public filings (which may be viewed at www.sedar.com). Information contained in this presentation is qualified in its entirety by such public filings.
            Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by
            the forward-looking statements contained in this presentation. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements
            contained in the presentation are based upon what management currently believes to be reasonable assumptions as of the date of this presentation, the Company cannot assure prospective investors that actual results, performance or achievements
            will be consistent with these forward-looking statements. This presentation does not constitute an offer to sell any class of securities of the Company in any jurisdiction. There is no assurance as to the whether hospitals will purchase at
            assumed prices. The Company does not forecast what portion of the total addressable market it will be able to capture. On slide 6, the Company assumes that the information presented in Intuitive Surgical’s news release is accurate, but has not
            independently verified the information.     Forward-looking Statements 

      

    

     

    
      
        


    

    
      
        

      

      
         Titan Medical Overview  Designer and developer of the SPORT Surgical System, a versatile single-port
            platform that is intended to address a growing multibillion-dollar* market for abdominal surgeries performed using robotic technology. Designed for improved clinical performance, ease of use, operating room efficiency, and hospital economics.
              *Robotically Assisted Surgical (RAS) Devices market to grow at 11.7% CAGR for the next 5 years and reach $5.3 billion in 2021, RAS Devices Market Report, Meddevicetracker Group.  4 

      

    

     

    
      
        


    

    
      
        

      

      
         Novel Clinical Paradigm  Multi-articulated triangulation through a single incision  Promising Physician
            Feedback  Tested by international surgeons from 4 surgical disciplines45 preclinical studies 9 peer-reviewed abstract presentations and one published manuscript  Robust IP Portfolio  100+ global patents and applications  Disruptive Business
            Model  Projected savings on capital equipment, service and procedure costsCompelling recurring revenue model  Commercial Momentum  U.S. launch planned in 2020 using direct sales strategy  Favorable Market Dynamics  Large, underpenetrated
            marketApplicable to multiple minimally invasive procedures  Investment Highlights 

      

    

     

    
      
        


    

    
      
        

      

      
         Open surgery offers broad applicationRequires significant hospital stay and recovery timeRisk of adverse
            events  Evolution of Surgical Care  * Press Release: Intuitive Surgical Announces Preliminary Fourth Quarter and Full Year 2018 Results, January 9, 2019   Minimally Invasive Surgery (MIS) has been a growing trend over the past 25 yearsReduced
            hospitalization timeReduced risk of adverse eventsRequires highly skilled surgeons  Robotic surgery further expands upon the benefits of MISOver 1 million* global robotic procedures were performed in 2018Technology remains expensive with
            procedural and operational limitations  Application of da Vinci® Single-Site in GYN and general surgery shows early promiseda Vinci SP® single port robotic system received FDA clearance for urology in 2018Robotic visualization, precision and
            dexterity with triangulation delivered through a single incision – such as the SPORT System – the next frontier. 

      

    

     

    
      
        


    

    
      
        

      

      
         Today’s Robotic Surgery Environment  Robotic technology was introduced to mitigate the risks of MIS,
            reduce variations in procedural efficiency and improve consistency of patient outcomes.  Benefits  Increased DexterityImproved Visualization (3D)Improved Ergonomics  The SPORT Surgical System offers the benefits of multi-articulated surgery
            through a single point of entry at a targeted lower cost. 

      

    

     

    
      
        


    

    
      
        

      

      
         Technology DifferentiationEngineered for Simplicity and Efficiency                          Single-
            IncisionWith a single incision made around the umbilicus, the result can be near-scarless surgery  Small FootprintEnhanced mobility and ease-of-use leads to quicker deployment in multiple ORs and higher utilization  Multi-ArticulatingSingle-use
            end-effectors on reusable multi-articulating instrument arms result in optimal and economical device performance in every procedure  Open Display3D high-definition display offers the perfect balance of surgical immersion and situational
            awareness in the OR  Ergonomic WorkstationHighly ergonomic workstation with natural handle interface enables comfortable surgical posture, even during long procedures   PurposefulDesignDesigned from the ground up to improve:Clinical
            CapabilitiesOR EfficiencyHospital Economics   

      

    

     

    
      
        


    

    
      
        

      

      
         System Overview  Versatile single-port robotic surgery solutionSmaller OR footprint than multiport
            systemsDesigned to overcome multi-port robotic surgery limitationsEngineered for performance, efficiency and cost-effectivenessExpected to provide access to underserved market segments, such as ambulatory surgery centers  9 

      

    

     

    
      
        


    

    
      
        

      

      
         Workstation  Open, unobtrusive 3D high-definition display platform on a 4K monitor  Integrated software
            for simulation training (in collaboration with Mimic Technologies, Inc.)  Ergonomically focused design  Easily maneuverable with swiveling easy-gliding coasters  Multi-configurable elbow rest and foot pedal positioning  Natural
            multi-articulated handle interface  10 

      

    

     

    
      
        


    

    
      
        

      

      
         Patient Cart  Easy to load and unload instruments through a detachable camera insertion tube   Compact,
            rollers enable mobility to maneuver and position   Single-arm configuration with no external moving parts facilitates simple setup and assistant-friendly surgery  Instruments and 3D high-definition camera delivered through a camera insertion
            tube of 25 millimeter diameter  Minimal cable management in OR  Single-port enables swift multi-quadrant positioning  11 

      

    

     

    
      
        


    

    
      
        

      

      
         Multi-Articulated Instruments  Hunter Style Grasper  Dissector  Hook  Needle Driver  Traditional
            Grasper  Scissors  monopolar compatible  monopolar compatible  bipolar compatible  S-Works Section  Distal Section  translational movement  2 axis multi-articulated movement  Tip Section  rotation + open/close movement  Variety of multi-use
            instruments with single patient use end effectors for grasping, suturing, cutting and coagulation  bipolar compatible  Open architecture for adaptation of future end effectors and functionality 

      

    

     

    
      
        


    

    
      
        

      

      
         Single-IncisionSurgery + Enhanced Robotic Technology    SPORT Surgical System is designed to provide
            surgeons with multi-articulated instruments in a triangulated configuration through single-port access to the body.  Optimal PatientCare   

      

    

     

    
      
        


    

    
      
        

      

      
                                     Areas of the SPORT Surgical System covered by patents or pending
            applications:  Intellectual PropertyThe SPORT Surgical System is a unique single-incision robotic system that is differentiated by its patented multi-articulating instruments, user interface and ergonomic features.Differentiated and innovative
            design provides a strong position on freedom to operate.  30  U.S. & International Patents Issued  77  Applications Pending 

      

    

     

    
      
        


    

    
      
        

      

      
         Proven Feasibility in Wide Variety of Procedures45 Procedures Performed to Date (live porcine unless
            otherwise indicated)  GYN and GYN-ONC (8 procedures at Columbia University and Florida Hospital):Radical Hysterectomy with Bilateral Salpingo Oophorectomy and Bilateral Pelvic / Para-Aortic Node DissectionSimple Hysterectomy with Bilateral
            Salpingo Oophorectomy and Bilateral Pelvic Node DissectionSimple Hysterectomy with Bilateral Salpingo OophorectomyUrology (19 procedures at IHU Strasbourg and Florida Hospital):Hemi-Nephrectomy and Partial NephrectomyProstatectomy (Human
            Cadaver)PyeloplastyUreteral-Bladder AnastomosisGeneral Surgery (14 procedures at IHU Strasbourg and Florida Hospital):Cholecystectomy (1 Human Cadaver, 5 Live Porcine)Nissen Fundoplication (1 Human Cadaver, 3 Live Porcine)Esophagectomy (Human
            Cadaver)GastrectomySplenectomyColorectal (4 procedures at Florida Hospital):ColectomyLow Anterior Resection 

      

    

     

    
      
        


    

    
      
        

      

      
           Multi-disciplinary applications of a new robotic platform by Barbara Seeliger, MD and Lee Swanstrom, MD
            (IHU Strasbourg)Accepted and presented at Society of American Gastrointestinal and Endoscopic Surgeons Meeting, Seattle, WA, April 2018 Single-port prostatectomy using SPORT Surgical System by Eric Barret, MD (IMM, France)Accepted and presented
            at EAU Section of Urology Technology Meeting, Modena, Italy, May 2018Multispecialty single port robotic technology applied in the live animal model: proof of concept by Travis Rogers, MD, Eduardo Parra Davila, MD, Vipul Patel, MD (all from
            Florida Hospital), Ricardo Estape, MD (South Miami GOG) and Armando Melani, MD (IRCAD Brazil) Accepted and presented as a poster at Society of Robotic Surgery Meeting, Stockholm, Sweden, June 2018Feasibility of single-port partial nephrectomy
            using SPORT surgical system by Eric Barret, MD (IMM, France)Accepted and presented as a poster at Society of Robotic Surgery Meeting, Stockholm, Sweden, June 2018Single-port robotic partial and hemi nephrectomy using a novel single port robotic
            platform by Sebastien Crouzet, MD (University of Lyon, France) and Barbara Seeliger, MD (IHU Strasbourg)Accepted and presented at EAU Robotic Urology Section Meeting, Marseille, France, September 2018Reverse Objective Structured Assessment of
            Technical Skills (Reverse-OSATS) as a means of measuring the capability of the Titan Medical SPORT Surgical System on core surgical principles by Chetna Arora, MD, Arnold P. Advincula, MD (both from Columbia University Medical Center) and
            William B. Burke, MD (Stony Brook Cancer Center)Accepted and presented at Society of European Robotic Gynecologic Surgeons Meeting, Milan, Italy, September 2018Multispecialty single port robotic technology applied in the live animal model:
            proof of concept by Travis Rogers, MD, Eduardo Parra Davila, MD, Vipul Patel, MD (all from Florida Hospital), Ricardo Estape, MD (South Miami GOG) and Armando Melani, MD (IRCAD Brazil) Accepted and presented at World Congress of Endourology
            Meeting, Paris, France, September 2018Feasibility of single-port partial nephrectomy using SPORT surgical system by Eric Barret, MD (IMM, France)Accepted and presented at World Congress of Endourology Meeting, Paris, France, September
            2018Reverse Objective Structured Assessment of Technical Skills (Reverse-OSATS) as a means of measuring the capability of the Titan Medical SPORT Surgical System on core surgical principles by Chetna Arora, MD, Arnold P. Advincula, MD (both
            from Columbia University Medical Center) and William B. Burke, MD (Stony Brook Cancer Center)Accepted and presented at American Association of Gynecologic Laparoscopists Global Congress, Las Vegas, NV, November 2018  SPORT single-port robotic
            surgery is feasible & repeatable.  Peer-reviewed Abstracts to Date 

      

    

     

    
      
        


    

    
      
        

      

      
         Published Manuscript  Surgical EndoscopyEnabling single-site laparoscopy: the SPORT platform       
                                                                                                                                                                                                                                       Barbara Seeliger1 ·
            Michele Diana1 · Jelle P. Ruurda2 · Konstantinos M. Konstantinidis3 · Jacques Marescaux1 · Lee L. Swanström1,4   1 IHU-Strasbourg Institute of Image-Guided Surgery, 1, place de l’Hôpital, 67091 Strasbourg Cedex, France 2 Department of
            Surgical Oncology, University Medical Center, Utrecht, Utrecht, Netherlands 3 Department of General, Bariatric, Laparoscopic and Robotic Surgery, Athens Medical Center, Athens, Greece 4 Division of GI/MIS, The Oregon Clinic, Portland, OR, USA  

      

    

     

    
      
        


    

    
      
        

      

      
           Commercial Timeline    2018  2019  2020  Established US & EU Centers of Excellence        Proven
            Feasibility        Integrated Simulation Training        Engineering Confidence Build        Design Freeze    H1    GLP Animal Studies    H1    IDE Approval    H2    Submit 510(K) Application    H2    Submit Technical File for CE
            Mark    H2    Anticipated Regulatory Clearance        Projected Initial Launch       

      

    

     

    
      
        


    

    
      
        

      

      
         Targeting growing multibillion-dollar global robotic surgery marketHighly versatile, differentiated
            advanced single-port platformDesigned for improved clinical performance, ease of use, operating room efficiency and hospital economicsPotential benefits to patients, surgeons and hospitals versus competitive offeringsSystem performance verified
            in preclinical studies with data presented at clinical conferencesAttractive capital and recurring revenue streams expectedExperienced management team with record of success  Summary 

      

    

     

    
      
        


    

    
      
        

      

      
         Thank YouTSX: TMD | Nasdaq: TMDI